These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24011247)

  • 1. Treatment of Helicobacter pylori infection 2013.
    O'Connor A; Molina-Infante J; Gisbert JP; O'Morain C
    Helicobacter; 2013 Sep; 18 Suppl 1():58-65. PubMed ID: 24011247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Helicobacter pylori infection 2014.
    O'Connor A; Vaira D; Gisbert JP; O'Morain C
    Helicobacter; 2014 Sep; 19 Suppl 1():38-45. PubMed ID: 25167944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Helicobacter pylori infection.
    O'Connor A; Gisbert J; O'Morain C
    Helicobacter; 2009 Sep; 14 Suppl 1():46-51. PubMed ID: 19712168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonbismuth quadruple (concomitant) therapy: empirical and tailored efficacy versus standard triple therapy for clarithromycin-susceptible Helicobacter pylori and versus sequential therapy for clarithromycin-resistant strains.
    Molina-Infante J; Pazos-Pacheco C; Vinagre-Rodriguez G; Perez-Gallardo B; Dueñas-Sadornil C; Hernandez-Alonso M; Gonzalez-Garcia G; Mateos-Rodriguez JM; Fernandez-Bermejo M; Gisbert JP
    Helicobacter; 2012 Aug; 17(4):269-76. PubMed ID: 22759326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'Rescue' therapies for the management of Helicobacter pylori infection.
    Di Mario F; Cavallaro LG; Scarpignato C
    Dig Dis; 2006; 24(1-2):113-30. PubMed ID: 16699270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Helicobacter pylori Infection 2015.
    O'Connor A; Gisbert JP; O'Morain C; Ladas S
    Helicobacter; 2015 Sep; 20 Suppl 1():54-61. PubMed ID: 26372826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori infection: sequential therapy followed by levofloxacin-containing triple therapy provides a good cumulative eradication rate.
    Manfredi M; Bizzarri B; de'Angelis GL
    Helicobacter; 2012 Aug; 17(4):246-53. PubMed ID: 22759323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Helicobacter pylori-related diseases].
    Gisbert JP
    Gastroenterol Hepatol; 2012 Sep; 35 Suppl 1():12-25. PubMed ID: 23018004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eradication of Helicobacter pylori: recent advances in treatment.
    McLoughlin RM; O'Morain CA; O'Connor HJ
    Fundam Clin Pharmacol; 2005 Aug; 19(4):421-7. PubMed ID: 16011728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of two levofloxacin-containing second-line therapies for Helicobacter pylori: a pilot study.
    Calhan T; Kahraman R; Sahin A; Senates E; Doganay HL; Kanat E; Ozdil K; Sokmen HM
    Helicobacter; 2013 Oct; 18(5):378-83. PubMed ID: 23601026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Helicobacter pylori infection 2016.
    O'Connor A; Fischbach W; Gisbert JP; O'Morain C
    Helicobacter; 2016 Sep; 21 Suppl 1():55-61. PubMed ID: 27531541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practical Aspects in Choosing a Helicobacter pylori Therapy.
    Molina-Infante J; Shiotani A
    Gastroenterol Clin North Am; 2015 Sep; 44(3):519-35. PubMed ID: 26314666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Helicobacter pylori.
    Egan BJ; Katicic M; O'Connor HJ; O'Morain CA
    Helicobacter; 2007 Oct; 12 Suppl 1():31-7. PubMed ID: 17727458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Helicobacter pylori infection 2011.
    O'Connor A; Gisbert JP; McNamara D; O'Morain C
    Helicobacter; 2011 Sep; 16 Suppl 1():53-8. PubMed ID: 21896086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori.
    Gisbert JP; Calvet X
    Aliment Pharmacol Ther; 2011 Sep; 34(6):604-17. PubMed ID: 21745241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practical treatment of Helicobacter pylori: a balanced view in changing times.
    Smith SM; Haider RB; O'Connor H; McNamara D; O'Morain C
    Eur J Gastroenterol Hepatol; 2014 Aug; 26(8):819-25. PubMed ID: 24892516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward population specific and personalized treatment of Helicobacter pylori infection.
    Liou JM; Chen PY; Kuo YT; Wu MS;
    J Biomed Sci; 2018 Oct; 25(1):70. PubMed ID: 30285834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes of two-week sequential and concomitant therapies for Helicobacter pylori eradication: a randomized pilot study.
    Lim JH; Lee DH; Choi C; Lee ST; Kim N; Jeong SH; Kim JW; Hwang JH; Park YS; Lee SH; Shin CM; Jo HJ; Jang ES; Song Is; Jung HC
    Helicobacter; 2013 Jun; 18(3):180-6. PubMed ID: 23305083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current options for the treatment of Helicobacter pylori.
    Georgopoulos SD; Papastergiou V; Karatapanis S
    Expert Opin Pharmacother; 2013 Feb; 14(2):211-23. PubMed ID: 23331077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rifabutin- and furazolidone-based Helicobacter pylori eradication therapies after failure of standard first- and second-line eradication attempts in dyspepsia patients.
    Qasim A; Sebastian S; Thornton O; Dobson M; McLoughlin R; Buckley M; O'Connor H; O'Morain C
    Aliment Pharmacol Ther; 2005 Jan; 21(1):91-6. PubMed ID: 15644050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.